Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis

PURPOSE: The aim of this study was to explore the value of adjuvant chemotherapy in patients with early-stage ER/PR-positive mucinous carcinoma. METHODS: We identified early-stage ER/PR-positive mucinous carcinoma patients in the Surveillance, Epidemiology, and End Results (SEER) database. We used p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast
Main Authors: Gao, Hong-Fei, Li, Wei-Ping, Zhu, Teng, Yang, Ci-Qiu, Yang, Mei, Zhang, Liu-Lu, Ji, Fei, Cheng, Min-Yi, Li, Jie-Qing, Wang, Kun
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7502365/
https://ncbi.nlm.nih.gov/pubmed/32947149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2020.09.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares